Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?

Authors: Harris, H. E.1; Eldridge, K. P.1; Harbour, S.2; Alexander, G.3; Teo, C.-G.2; Ramsay, M. E.1

Source: Journal of Viral Hepatitis, Volume 14, Number 3, March 2007 , pp. 213-220(8)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Summary. 

Whether differences in the natural history of hepatitis C virus (HCV) can be explained by differences in the infecting HCV type is unknown. The aim of this study was to investigate whether the HCV type might influence the clinical outcome of infection. Study serum samples were assembled from 749 individuals enrolled into the UK HCV National Register from which data on clinical outcomes were extracted. HCV-RNA-positive specimens were genotyped and HCV-RNA-negative specimens serotyped. Logistic regression analysis was used to investigate the independent effect of HCV type on viral clearance by comparing patients who were HCV RNA negative (n = 86) with those who were HCV RNA positive (n = 508). The same method was used to investigate whether HCV type was associated with histological stage of liver disease. The prevalence of HCV type 1 among those who cleared infection was 69% and among those who remained HCV RNA positive was 51%: Type 1 infections were more likely to be HCV RNA negative than non-1 types (OR 0.47, 95% CI 0.29-0.78, P = 0.003). Type 1 infections were also more likely to be associated with histological stage scores above the median when compared with non-1 types (OR 2.03, 95% CI 1.07-3.83, P = 0.03). In conclusion, HCV type 1 infection was more often HCV RNA negative, suggesting that spontaneous clearance may occur more commonly with this type. Among the RNA-positive infections, type 1 infection may be more aggressive than types 2/3.

Keywords: genotype; hepatitis C; liver disease; natural history; serotype

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1365-2893.2006.00795.x

Affiliations: 1: Immunisation Department, Centre for Infections, Health Protection Agency, London 2: Sexually Transmitted and Blood-Borne Virus Laboratory, Centre for Infections, Health Protection Agency, London 3: Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK

Publication date: 2007-03-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page